Health ❯ Medicine ❯ Pharmaceuticals

Drug Development

Clinical Trials Obesity Treatments Weight Loss Drugs Alzheimer's Disease Cholesterol Management Quantum Computing in Medicine Daraxonrasib Pain Medication Inflammatory Bowel Disease Epilepsy Treatment

Lilly Plans Q1 2027 U.S. Filing for Retatrutide After Two More Positive Phase 3 Trials

Regulators will weigh a reported cardiovascular safety signal during Lilly's manufacturing verification.

Ipsen Says Dysport Met Phase 3 Endpoints for Episodic and Chronic Migraine

Immunovant Shares Surge on Strong Rheumatoid Arthritis Data for IMVT-1402

FDA Grants Orphan Drug Status to Immutep’s Efti for Soft Tissue Sarcoma

Xenon to Present Topline X-TOLE2 Phase 3 Results in Focal Onset Seizures at 8 A.M. ET Today

EMA Backs Single-Dose Acoziborole for Gambiense Sleeping Sickness Outside EU

Novo’s Triple-Hormone Obesity Drug UBT251 Hits 19.7% Mean Weight Loss in China Phase 2

Pfizer’s Monthly Obesity Shot Shows Mid-Stage Gains With Up to 12.3% Weight Loss

Lilly and Nimbus Strike Multi-Year AI Deal for Oral Obesity Drugs

Takeda’s AI-Assisted Psoriasis Pill Succeeds in Phase 3, Outperforms Otezla

Sanofi Secures Global Rights to ADEL’s Alzheimer’s Antibody in Deal Worth Up to $1.04 Billion

Pharvaris’ Oral HAE Drug Deucrictibant Delivers Rapid Relief in Pivotal Phase 3

Novo Nordisk Halts Phase-3 Alzheimer’s Trial of Semaglutide After Failure to Slow Decline

Merck to Buy Cidara for $9.2 Billion to Secure Long-Acting Flu Drug

Merck’s Oral PCSK9 Pill Matches Injectables in Phase 3, Setting Up 2026 FDA Bid

FDA Reapproves GSK’s Blenrep for Multiple Myeloma in Narrow Combination Use

Google’s ‘Quantum Echoes’ Claims 13,000× Speedup on Willow in Peer-Reviewed Study

Trump Urges Pregnant Women to Avoid Paracetamol Over Autism Risk

Scientists Renew Push to Ban 'Mirror Life' Research After New Warning

Wegovy Becomes First GLP-1 Therapy Approved by FDA for MASH